RO6864018
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RO6864018, covering 2017-03-01 to 2018-06-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection [Phase 2]